Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 1/20 | 0.51 |
| ▸ | CETP | P11597 | 3/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30759387 | 1.00 | ALDH1A1 (0.54) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL16648567 | 0.95 | ALDH1A1 (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL16648564 | 0.95 | ALDH1A1 (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL2677628 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL7305728 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL7305733 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL3736932 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL21245794 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL27424922 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 | |
| SCHEMBL16648466 | 0.94 | CETP (0.52) | ALDH1A1MAPK1TDP1L3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108137515-A | Hydroxy triazine compound and medical use thereof | 日本烟草产业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| CN-102470181-B | e-polylysine conjugates and use thereof | MERCK PATENT GMBH | 2014-12-03 | — | — | CN | disclosed |
| CN-102470181-A | Polylysine conjugates and uses thereof | MERCK PATENT GMBH | 2012-05-23 | — | — | CN | disclosed |
| EP-1105399-B1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH SA (CH) | 2004-04-14 | — | — | EP | disclosed |
| US-6706280-B2 | DRUG TARGETING WITH LIPOSOMES AND MAGNETIC RESONANCE IMAGING CONTRAST MEDIA FOR DIAGNOSTICS | BRACCO RESEARCH S.A. (CH) | 2004-03-16 | — | — | US | disclosed |
| EP-0574174-B1 | Angiotensin II antagonists | LILLY CO ELI (US) | 2003-08-13 | — | — | EP | disclosed |
| EP-0993442-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-04-23 | — | — | EP | disclosed |
| US-20020136760-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH S.A. (CH) | 2002-09-26 | — | — | US | disclosed |
| EP-1105399-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH S.A. (CH) | 2001-06-13 | — | — | EP | disclosed |
| US-6242514-B1 | CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
| EP-0993442-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-04-19 | — | — | EP | disclosed |
| WO-2000011007-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | BRACCO RESEARCH S.A. (CH) | 2000-03-02 | — | — | WO | disclosed |
| US-5914361-A | IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-06-22 | — | — | US | disclosed |
| WO-1999001428-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-01-14 | — | — | WO | disclosed |
| US-5830936-A | THERMAL STABILIZERS FOR POLYOLEFINS AND ENGINEERING PLASTICS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-11-03 | — | — | US | disclosed |
| US-5693633-A | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1997-12-02 | — | — | US | disclosed |
| US-5612360-A | AROMATIC N-HETEROCYCLIC COMPOUNDS AS HYPOTENSIVE AGENTS WITH ACID GROUPS, SULFONYLCARBOXAMIDES OR TETRAZOLE GROUPS | ELI LILLY AND COMPANY (US) | 1997-03-18 | — | — | US | disclosed |
| US-5569768-A | USEFUL IN TREATING HYPERTENSION, CONGESTIVE HEART FAILURE, GLAUCOMA AND RENAL INSUFFICIENCY | ELI LILLY AND COMPANY (US) | 1996-10-29 | — | — | US | disclosed |
| US-5556981-A | Angiotensin II antagonist intermediates | ELI LILLY AND COMPANY (US) | 1996-09-17 | — | — | US | disclosed |
| EP-0574174-A2 | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1993-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020136760-A1 | CARBOXYLATED PHOSPHATIDIC ACID ESTERS | PHOSPHO1, PLD1, SGMS1 | ALDH1A1 1522/4885MAPK1 2643/4885TDP1 3199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.